Internal Medicine, Medical Oncology · Attleboro, MA
NPI
1598925091
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
28 Sturdy St
Attleboro, MA, 02703
Phone (508) 236-8525
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
1,266 services
Medicare patients, 2024
419
Average age 75
Drug cost, 2024
$3.2M
1,025 prescriptions
Company payments, 2025
$227
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth D Bishop was code 99214 (office e&m - established), 681 times for 293 patients. In total Kenneth D Bishop billed 1,266 services in 25 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 681 | 293 | $91.86 | $63K |
| 99213 Office E&M - Established | Office | 189 | 130 | $64.49 | $12K |
| 99215 Office E&M - Established | Office | 122 | 72 | $138.43 | $17K |
| 36415 Venipuncture Blood Collection | Office | 98 | 39 | $8.65 | $848 |
| 99204 Office E&M - New | Office | 36 | 36 | $124.41 | $4,479 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 22 | $61.84 | $1,917 |
By year: 2022 $113K for 1,276 services; 2023 $117K for 1,356 services; 2024 $105K for 1,266 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 98 | 39 | $8.65 | $848 |
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth D Bishop prescribed most often to Medicare patients was Eliquis (Apixaban), with 93 prescriptions and refills. In total Kenneth D Bishop wrote 1,025 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 93 | 123 | 19 | $70K |
| Dexamethasone Generic | 55 | 58 | 14 | $591 |
| Oxycodone Hcl Generic | 53 | 53 | Under 11 | $480 |
| Hydroxyurea Generic | 50 | 116 | 15 | $1,447 |
| Imbruvica Ibrutinib | 42 | 42 | Under 11 | $587K |
| Potassium Chloride Generic | 40 | 62 | Under 11 | $544 |
| Ondansetron Hcl Generic | 37 | 41 | 21 | $384 |
| Revlimid Lenalidomide | 31 | 31 | Under 11 | $559K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 27 | 27 | Under 11 | $159K |
| Omeprazole Generic | 27 | 51 | Under 11 | $175 |
| Lenalidomide Generic | 25 | 25 | Under 11 | $199K |
| Xtandi Enzalutamide | 24 | 24 | Under 11 | $269K |
| Gabapentin Generic | 23 | 23 | Under 11 | $377 |
| Anastrozole Generic | 23 | 65 | Under 11 | $348 |
| Prednisone Generic | 22 | 22 | Under 11 | $129 |
Brand drugs: 316 claims; generic drugs: 709 claims; opioid claims: 102.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth D Bishop $227 ($227 in general payments such as food, travel and fees) from 3 companies. The largest payer was Astellas Pharma US Inc with $178.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.